Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-31

Clinical Trial Update: A Long-term Study for the Treatment of Painful Diabetic Neuropathy [Phase 3]

View source ↗

Summary

A long-term Phase 3 study evaluating the treatment of painful diabetic neuropathy completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cymbalta (duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetic Neuropathies | Phase 3 | Status: COMPLETED | Results posted: 2011-03-31